Folotyn: payments to doctors
Payments that named Folotyn as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $135K
- Providers
- 899
- Transactions
- 1,852
- Average per transaction
- $73
The per-transaction average — $73 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 899 providers the average total is $150, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Aurobindo Pharma USA, Inc. | $103,117 | 76.3% |
| Acrotech Biopharma LLC | $17,774 | 13.2% |
| Spectrum Pharmaceuticals Inc. | $13,948 | 10.3% |
| Acrotech Biopharma Inc. | $257 | 0.2% |